Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 9 de 9
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
Br J Dermatol ; 2024 Jun 24.
Article de Anglais | MEDLINE | ID: mdl-38912785

RÉSUMÉ

BACKGROUND: Psoriatic disease (PsD) is closely associated with cardiovascular diseases. The Life's Essential 8 (LE8) score is a new metric for assessing cardiovascular health (CVH), where a higher score indicates better CVH. However, the longitudinal association between LE8 score and the risk of PsD remains uncertain. The main aim of the present study was to explore the association between LE8 scores and the risk of PsD. OBJECTIVE: To investigate the associations between LE8 score, genetic susceptibility, and the risk of PsD within a cohort design. METHODS: This cohort study included 261,642 participants from the UK Biobank without PsD at baseline. LE8 comprises eight indicators: diet, physical activity, nicotine exposure, sleep health, body mass index, blood lipids, blood glucose, and blood pressure. Cox proportional hazard models were employed to examine the association between the participants' LE8 scores, PsD genetic risk, and the risk of PsD. Hazard ratios (HRs) and 95% confidential intervals (CIs) were calculated. RESULTS: During an average follow-up of 12.32 years, 1,501 participants developed PsD. Compared to participants with low LE8 scores, the HRs (95% CIs) of developing PsD for those with moderate and high LE8 scores were 0.51 (0.43, 0.59) and 0.34 (0.27, 0.42) after adjustments, respectively. Dose-response analysis revealed a linear negative association between continuous LE8 score and the risk of developing PsD (P < 0.001), with no evidence of non-linear association detected. The genetic susceptibility to PsD did not modify this association (P for interaction = 0.63). Subgroup analyses revealed that women demonstrated a more pronounced beneficial association between LE8 scores and PsD risk (P for interaction = 0.02). CONCLUSIONS: Our study suggests that a higher LE8 score, regardless of genetic risk, was associated with a lower risk of PsD, particularly among women. Consequently, maintaining a high CVH status is recommended to prevent PsD and assess associated risks.

2.
Biosci Biotechnol Biochem ; 84(10): 2005-2013, 2020 Oct.
Article de Anglais | MEDLINE | ID: mdl-32564679

RÉSUMÉ

Atopic dermatitis (AD) is a relapsing inflammatory skin disease with a complicated pathogenesis. This study aimed to investigate whether miR-375-3p could regulate AD through the Yes-associated protein 1 (YAP1) pathway. In this study, inflammatory response was induced by TNF-α and IFN-γ administration in HaCaT cells. We found that viability and inflammatory factor release, including interleukin-1ß (IL-1ß) and IL-6, were negatively related to miR-375-3p expression in HaCaT cells. We also found that YAP1 overexpression down-regulated lympho-epithelial Kazal type inhibitor (LEKTI) levels and aggravated viability and inflammation in TNF-α and IFN-γ-treated HaCaT cells. Dual-luciferase reporter assay proved the targeted binding of miR-375-3p and YAP1 3'-UTR. Additionally, the protective effect of miR-375-3p on inflammatory response in TNF-α and IFN-γ-treated HaCaT cells could be impeded by YAP1 overexpression. Collectively, our results suggested that miR-375-3p could modulate HaCaT cell viability and inflammation through the YAP1/LEKTI pathway.


Sujet(s)
Protéines adaptatrices de la transduction du signal/métabolisme , microARN/génétique , Inhibiteur de sérine peptidase de type Kazal-5/métabolisme , Transduction du signal/génétique , Facteurs de transcription/métabolisme , Lignée cellulaire , Survie cellulaire/génétique , Humains , Inflammation/génétique , Transcriptome/génétique , Protéines de signalisation YAP
4.
Skin Pharmacol Physiol ; 30(5): 268-276, 2017.
Article de Anglais | MEDLINE | ID: mdl-28873377

RÉSUMÉ

BACKGROUND AND OBJECTIVES: The objective of this study was to evaluate the topical effects of sea buckthorn (SBT) oil on atopic dermatitis (AD)-like lesions in a mouse model generated by repeated topical administration of DNCB in BALB/c mice. METHODS: DNCB was applied repeatedly on the dorsal skin of mice to induce AD-like lesions. Following AD induction, SBT oil was applied daily on the dorsal skin for 4 weeks. The severity of skin lesions was examined macroscopically and histologically. We further measured the production of MDC/CCL22 and TARC/CCL17 in IFN-γ/TNF-α activated HaCaT cells. RESULTS: Topically applied SBT oil in DNCB-treated mice ameliorated the severity score of dermatitis, decreased epidermal thickness, reduced spleen and lymph node weights, and prevented mast cell infiltration. In addition, SBT oil suppressed the Th2 chemokines TARC and MDC via dose-dependent inhibition of NF-κB, JAK2/STAT1, and p38-MAPK signaling pathways in IFN-γ/TNF-α-activated HaCaT cells. CONCLUSION: These results suggest that SBT oil had a beneficial effect on AD-like skin lesions, partially via inhibition of the Th2 chemokines TARC and MDC in inflamed skin.


Sujet(s)
Eczéma atopique/traitement médicamenteux , Hippophae , Huiles végétales/usage thérapeutique , Animaux , Lignée cellulaire , Chimiokine CCL17/métabolisme , Chimiokine CCL22/métabolisme , Eczéma atopique/métabolisme , Eczéma atopique/anatomopathologie , 1-Chloro-2,4-dinitro-benzène , Femelle , Humains , Irritants , Noeuds lymphatiques/effets des médicaments et des substances chimiques , Souris de lignée BALB C , Facteur de transcription NF-kappa B/antagonistes et inhibiteurs , Facteur de transcription NF-kappa B/métabolisme , Huiles végétales/pharmacologie , Facteur de transcription STAT-1/antagonistes et inhibiteurs , Facteur de transcription STAT-1/métabolisme , Peau/effets des médicaments et des substances chimiques , Peau/métabolisme , Peau/anatomopathologie , Rate/effets des médicaments et des substances chimiques
5.
Chin Med J (Engl) ; 129(3): 295-303, 2016 Feb 05.
Article de Anglais | MEDLINE | ID: mdl-26831231

RÉSUMÉ

BACKGROUND: Atopic dermatitis (AD) is characterized by defective skin barrier and imbalance in T helper 1/T helper 2 (Th1/Th2) cytokine expression. Filaggrin (FLG) is the key protein to maintaining skin barrier function. Recent studies indicated that Th1/Th2 cytokines influence FLG expression in keratinocytes. However, the role of Th1/Th2 cytokines on FLG processing is not substantially documented. Our aim was to investigate the impact of Th1/Th2 cytokines on FLG processing. METHODS: HaCaT cells and normal human keratinocytes were cultured in low and high calcium media and stimulated by either interleukin (IL)-4, 13 or interferon-γ (IFN-γ). FLG, its major processing proteases and key protease inhibitor lymphoepithelial Kazal-type-related inhibitor (LEKTI) were measured by both real-time quantitative polymerase chain reaction and Western blotting. Their expression was also evaluated in acute and chronic AD lesions by immunohistochemistry. RESULTS: IL-4/13 significantly reduced, while IFN-γ significantly up-regulated FLG expression. IL-4/13 significantly increased, whereas IFN-γ significantly decreased the expression of kallikreins 5 and 7, matriptase and channel-activating serine protease 1. On the contrary, IL-4/13 significantly decreased, while IFN-γ increased the expression of LEKTI and caspase-14. Similar trends were observed in AD lesions. CONCLUSIONS: Our results suggested that Th1/Th2 cytokines differentially regulated the expression of major FLG processing enzymes. The imbalance between Th1 and Th2 polarized immune response seems to extend to FLG homeostasis, through the network of FLG processing enzymes.


Sujet(s)
Eczéma atopique/métabolisme , Protéines de filaments intermédiaires/métabolisme , Kératinocytes/enzymologie , Kératinocytes/métabolisme , Lymphocytes auxiliaires Th1/métabolisme , Lymphocytes auxiliaires Th2/métabolisme , Caspase-14/métabolisme , Lignée cellulaire tumorale , Cellules cultivées , Protéines filaggrine , Humains , Immunohistochimie , Interféron gamma/métabolisme , Interleukine-13/métabolisme , Interleukine-4/métabolisme , Protéines sécrétoires inhibitrices de protéinases/métabolisme , Inhibiteur de sérine peptidase de type Kazal-5
6.
PLoS One ; 9(12): e115448, 2014.
Article de Anglais | MEDLINE | ID: mdl-25531302

RÉSUMÉ

BACKGROUND: Atopic dermatitis (AD) is the most prevalent chronic inflammatory skin disease in children characterized by dermatitis and pruritus. MicroRNAs (miRNAs) have been shown as great potential biomarkers for disease fingerprints to predict prognostics. We aimed to identify miRNA signature from serum and urine for the prognosis of AD patient by genome-wide miRNA profiling analysis. METHODS: Serum and urine from 30 children with AD and 28 healthy children were collected and their genome-wide miRNA expression profiles were measured by TaqMan-based array and confirmed by quantitative real-time PCR. Inflammatory factors in serum were detected by Antibody Array System. RESULTS: miR-203 and miR-483-5p were significantly up-regulated in serum of children with AD compared with healthy children. The level of miR-483-5p in serum was significantly associated with other atopic conditions, such as rhinitis and/or asthma. However, miR-203 was markedly decreased in urine of children with AD compared with healthy children. Down-regulated miR-203 in urine was significant associated with abnormal level of serum IgE in AD patients. 7 inflammatory factors in serum were altered in children with AD compared with healthy children. Up-regulated miR-203 in serum was significantly associated with increased sTNFRI and sTNFRII. CONCLUSIONS: Up-regulated miR-483-5p in serum may be indicative of other atopic conditions in children with AD. Down-regulated miR-203 in urine may serve as a biomarker for the severity of inflammation in children with AD.


Sujet(s)
Marqueurs biologiques/sang , Marqueurs biologiques/urine , Eczéma atopique/génétique , microARN/sang , microARN/urine , Études cas-témoins , Enfant , Enfant d'âge préscolaire , Eczéma atopique/sang , Eczéma atopique/urine , Femelle , Analyse de profil d'expression de gènes , Humains , Nourrisson , Médiateurs de l'inflammation/analyse , Mâle , Pronostic , Réaction de polymérisation en chaine en temps réel , Régulation positive
7.
Int J Pediatr Otorhinolaryngol ; 78(9): 1461-6, 2014 Sep.
Article de Anglais | MEDLINE | ID: mdl-24975403

RÉSUMÉ

OBJECTIVES: Mutations in the GJB2 gene encoding connexin 26 (Cx26) are major causes of hereditary deafness. This study aimed to characterize the mutation profiles of the GJB2 gene in a Chinese family with sensorineural hearing loss. METHODS: A Chinese family that included three individuals with sensorineural hearing loss and palmoplantar keratoderma underwent complete physical examinations, audiological examinations including pure tone audiometry and auditory brainstem response, skin pathological examination, and temporal CT scans. The entire coding region of GJB2, GJB3, GJB6, and the coding exons (exon7+8 and 19) of SLC26A4, mitochondrial 12SrRNA, and tRNA Ser (UCN) were sequenced. Structural analysis was performed to detect the effects of mutation on the tertiary structure of Cx26. RESULTS: A dominant GJB2 mutation, c.224G>A (p.Arg75Gln, p.R75Q), was detected in the family. No other mutation was identified in GJB2, GJB3, GJB6, or the coding exons (exon7+8 and 19) of SLC26A4, mitochondrial 12SrRNA, and tRNA Ser (UCN). Structural analysis revealed that the p.R75Q mutation likely affects the structural stability and permeation properties of the Cx26 gap junction channel. CONCLUSION: Our findings provide further evidence of a correlation between the p.R75Q mutation in Cx26 and a syndromic hearing impairment with palmoplantar keratoderma.


Sujet(s)
Asiatiques/génétique , Connexines/génétique , Surdité neurosensorielle/génétique , Kératose palmoplantaire/génétique , Mutation , Adulte , Chine , Connexine-26 , Femelle , Surdité neurosensorielle/complications , Humains , Kératose palmoplantaire/complications , Mâle , Adulte d'âge moyen , Pedigree
9.
Dermatol Ther ; 27(2): 109-12, 2014.
Article de Anglais | MEDLINE | ID: mdl-24703269

RÉSUMÉ

Genital warts acquired during pregnancy tend to grow fast, and management is challenging. We treated two cases of primipara with extensive genital warts by local hyperthermia at 44°C for 30 minutes a day for 3 consecutive days plus 2 additional days 1 week later, then once a week till there showed signs of clinical regression. The warty lesions in the patients resolved in 5 and 7 weeks, respectively. There was no sign of recurrence during a 6-month follow-up. This suggests that local hyperthermia seems to be a promising method for treating genital warts in pregnant women.


Sujet(s)
Condylomes acuminés/thérapie , Hyperthermie provoquée , Complications de la grossesse/thérapie , Condylomes acuminés/diagnostic , Condylomes acuminés/virologie , Femelle , Humains , Grossesse , Complications de la grossesse/diagnostic , Complications de la grossesse/virologie , Induction de rémission , Facteurs temps , Résultat thérapeutique , Jeune adulte
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE